Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
JCI Insight|August 12, 2024
Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastomaSanthoshkumar Sundaramoorthy, Daniele Filippo Colombo, Rajendran Sanalkumar, et al.
Cell Reports|May 28, 2013
An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastomaEsther Rheinbay, Mario L Suvà, Shawn M Gillespie, et al.
Cell|May 17, 2016
SIRT6 Suppresses Pancreatic Cancer through Control of Lin28bSita Kugel, Carlos Sebastián, Julien Fitamant, et al.
Developmental Cell|May 17, 2011
The WTX tumor suppressor regulates mesenchymal progenitor cell fate specificationAnnie Moisan, Miguel N Rivera, Sutada Lotinun, et al.
The Oncologist|December 9, 2022
Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case SeriesJamie O Brett, Lauren L Ritterhouse, Erik T Newman, et al.
Molecular Cell|August 18, 2022
Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progressionIoannis Sanidas, Hanjun Lee, Purva H Rumde, et al.
Science (New York, N.Y.)|January 6, 2007
An X chromosome gene, WTX, is commonly inactivated in Wilms tumorMiguel N Rivera, Woo Jae Kim, Julie Wells, et al.
Clinical and Translational Gastroenterology|January 19, 2021
LGR5 in Barrett's Esophagus and its Utility in Predicting Patients at Increased Risk of Advanced NeoplasiaAzfar Neyaz, Robert D Odze, Steffen Rickelt, et al.
The Journal of Biological Chemistry|March 12, 2010
A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathwayMyoung Shin Kim, Seung Kew Yoon, Frank Bollig, et al.
Pageof 8